Tenax Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Tenax Therapeutics

16/08/2023 03:12

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly
adjusted
loss of 5 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 10 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tenax Therapeutics Inc's reported EPS for the quarter was
a loss
of 5 cents​.
    * The mean earnings estimate of analysts had risen by
about 63% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Tenax Therapeutics Inc shares had fallen by 2.6% this
quarter and lost 86.9% so far this year.
    * The company reported a quarterly loss of $1.11 million.
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $5.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 16 at 02:12 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.10          -0.05          Beat
 Mar. 31 2023      -0.37          -0.15          Beat
 Dec. 31 2022      -2.28          -1.73          Beat
 Sep. 30 2022      -2.10          -2.20          Missed